GDC experienced a near-complete business collapse with revenue falling to almost negligible levels while shifting from China-US operations to US-focused operations only.
The company appears to have undergone a fundamental business transformation or failure, with revenue collapsing from $25M to just $153K while simultaneously ceasing meaningful operations in China. The dramatic reduction in inventory and receivables suggests either a complete wind-down of previous business activities or a major operational restructuring that has left the company as essentially a shell entity.
GDC's financial profile indicates a company in severe distress or transition, with revenue and gross profit both falling to near-zero levels while operating losses, though still substantial at $8.5M, improved from the prior year's $14.2M loss. Working capital components like inventory and accounts receivable collapsed alongside revenue, while the company maintained some liquidity by reducing total liabilities by 26%. The massive increase in outstanding shares from 12.3M to 60.8M suggests significant dilutive financing or restructuring activities during the period.
Inventory drawn down 99.6% — strong sell-through or deliberate destocking; watch for supply constraints.
Revenue declined 99.4% — significant demand weakness or market share loss warrants investigation.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Capex reduced 95.4% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Receivables declined — improved collection efficiency or conservative revenue recognition.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Liabilities reduced 26.2% — deleveraging improves balance sheet strength and financial flexibility.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
Current liabilities reduced — improved short-term financial position and working capital health.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →